Cartwright A C
J Pharm Pharmacol. 1979 Jul;31(7):434-40. doi: 10.1111/j.2042-7158.1979.tb13548.x.
Collaborative in vitro dissolution tests on a sample of commercial tolbutamide tablets and a sample of oxytetracycline capsules were carried out in eight laboratories. The two preparations tested showed differences between the products in release characteristics, particularly in the distintegration phase. This may have caused the difference in the pattern of variance in the two trials. In the case of tolbutamine tablets the value of the repeatability standard deviation was small, and therefore the major contribution to the variance was in the difference between laboratories. With oxytetracycline capsules the major contribution of the variance lies in the random errors common to all laboratories (i.e. the within-laboratory variance). One major source of inter-laboratory viance was identified as the level of vibration at the side of the dissolution flask. Another source of variation was found to be due to using a stated extinction coefficient instead of comparing the absorbances of the samples to those of a solution of a reference substance.
八个实验室对一批市售甲苯磺丁脲片和一批土霉素胶囊进行了体外协同溶出试验。所测试的两种制剂在释放特性上存在产品差异,尤其是在崩解阶段。这可能导致了两项试验中方差模式的差异。对于甲苯磺丁脲片,重复性标准偏差值较小,因此方差的主要贡献在于实验室之间的差异。对于土霉素胶囊,方差的主要贡献在于所有实验室共有的随机误差(即实验室内方差)。实验室间差异的一个主要来源被确定为溶出瓶一侧的振动水平。另一个变异来源被发现是由于使用规定的消光系数,而不是将样品的吸光度与参考物质溶液的吸光度进行比较。